Sun Pharmaceutical Industries Ltd to Sell Some Merck & Co., Inc. Diabetes Drugs in India

April 25, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

(Reuters) - Sun Pharmaceutical Industries Ltd has entered into a deal to market Merck's diabetes drugs -- sitagliptin and sitagliptin plus metformin -- in India, the two drugmakers said in a statement on Monday.

Twitter
LinkedIn
Facebook
Email
Print

Asia

Merck & Co.